CARBASTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carbastat, and when can generic versions of Carbastat launch?
Carbastat is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in CARBASTAT is carbachol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the carbachol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CARBASTAT?
- What are the global sales for CARBASTAT?
- What is Average Wholesale Price for CARBASTAT?
Summary for CARBASTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Patent Applications: | 4,158 |
| DailyMed Link: | CARBASTAT at DailyMed |
US Patents and Regulatory Information for CARBASTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | CARBASTAT | carbachol | SOLUTION;INTRAOCULAR | 073677-001 | Apr 28, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
